NattoPharma wins twice with K2
It’s been a good week for Norwegian supplier, NattoPharma, which has had its application for the safe addition of vitamin K2 (menaquonine) to various foods and food supplements accepted by the European Food Safety Authority (EFSA) and won a Frost & Sullivan award.
EFSA concluded vitamin K2, in the oil formulation it tested, is bioavailable as a source of vitamin K and that the menaquinone-rich edible oil was safe for use in foods and supplements except baby foods and infant formula.
The opinion was the “go-ahead signal” its clients had been waiting for to “step up commercial activities”, said NattoPharma president and CEO, Egil Greve.
Frost & Sullivan handed NattoPharma’s K2 version, MenaQ7, its Product Innovation of the Year Award for an ingredient that delivered clinically backed heart and bone health benefits. It was a “nice recognition”, a NattoPharma spokesperson said.
